Insider Transactions in Q4 2020 at Adtran Inc (ADTN)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
Roy J Nichols Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,094
+8.72%
|
-
|
|
Dec 31
2020
|
Roy J Nichols Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
0
|
$0
$14.77 P/Share
|
|
Dec 31
2020
|
Roy J Nichols Director |
BUY
Exercise of conversion of derivative security
|
Direct |
318
+0.55%
|
-
|
|
Dec 31
2020
|
H Fenwick Huss |
BUY
Grant, award, or other acquisition
|
Direct |
6,094
+10.43%
|
-
|
|
Dec 31
2020
|
H Fenwick Huss |
SELL
Sale (or disposition) back to the issuer
|
Direct |
0
|
$0
$14.77 P/Share
|
|
Dec 31
2020
|
H Fenwick Huss |
BUY
Exercise of conversion of derivative security
|
Direct |
318
+0.68%
|
-
|
|
Dec 31
2020
|
Balan Nair |
BUY
Grant, award, or other acquisition
|
Direct |
6,094
+8.53%
|
-
|
|
Dec 31
2020
|
Balan Nair |
SELL
Sale (or disposition) back to the issuer
|
Direct |
0
|
$0
$14.77 P/Share
|
|
Dec 31
2020
|
Balan Nair |
BUY
Exercise of conversion of derivative security
|
Direct |
318
+0.53%
|
-
|
|
Dec 31
2020
|
Kathryn A Walker |
BUY
Grant, award, or other acquisition
|
Direct |
6,094
+12.32%
|
-
|
|
Dec 31
2020
|
Kathryn A Walker |
SELL
Sale (or disposition) back to the issuer
|
Direct |
0
|
$0
$14.77 P/Share
|
|
Dec 31
2020
|
Kathryn A Walker |
BUY
Exercise of conversion of derivative security
|
Direct |
318
+0.85%
|
-
|
|
Dec 31
2020
|
Gregory James Mc Cray |
BUY
Grant, award, or other acquisition
|
Direct |
6,094
+16.15%
|
-
|
|
Dec 31
2020
|
Gregory James Mc Cray |
SELL
Sale (or disposition) back to the issuer
|
Direct |
0
|
$0
$14.77 P/Share
|
|
Dec 31
2020
|
Gregory James Mc Cray |
BUY
Exercise of conversion of derivative security
|
Direct |
318
+1.23%
|
-
|
|
Dec 31
2020
|
Hourigan Rice Jacqueline |
BUY
Grant, award, or other acquisition
|
Direct |
6,094
+50.0%
|
-
|
|
Dec 31
2020
|
Hourigan Rice Jacqueline |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
0
|
$0
$14.77 P/Share
|
|
Dec 31
2020
|
Hourigan Rice Jacqueline |
BUY
Exercise of conversion of derivative security
|
Indirect |
318
+1.08%
|
-
|
|
Dec 31
2020
|
Hourigan Rice Jacqueline |
BUY
Other acquisition or disposition
|
Indirect |
9,156
+24.12%
|
-
|
|
Dec 31
2020
|
Hourigan Rice Jacqueline |
SELL
Other acquisition or disposition
|
Direct |
9,156
-100.0%
|
-
|
|
Dec 01
2020
|
Marc Kimpe SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.04%
|
$132
$12.86 P/Share
|
|
Dec 01
2020
|
Gregory James Mc Cray |
BUY
Grant, award, or other acquisition
|
Direct |
52
+0.21%
|
$624
$12.71 P/Share
|
|
Dec 01
2020
|
Ronald Centis SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.01%
|
$24
$12.85 P/Share
|
|
Dec 01
2020
|
Ray Harris Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.01%
|
$24
$12.85 P/Share
|
|
Dec 01
2020
|
Eduard Scheiterer SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.06%
|
$228
$12.71 P/Share
|
|
Nov 16
2020
|
Ronald Centis SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
8,933
+28.9%
|
-
|
|
Nov 16
2020
|
Ray Harris Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,806
+30.54%
|
-
|
|
Nov 16
2020
|
Marc Kimpe SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
7,153
+22.46%
|
-
|
|
Nov 16
2020
|
Michael Foliano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,396
+16.6%
|
-
|
|
Nov 16
2020
|
Eduard Scheiterer SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
10,239
+14.38%
|
-
|
|
Nov 16
2020
|
Thomas R Stanton Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,246
+15.46%
|
-
|
|
Nov 16
2020
|
James Denson Wilson Jr Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,816
+22.08%
|
-
|
|
Nov 16
2020
|
Ray Harris Chief Information Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,270
-20.75%
|
$27,240
$12.39 P/Share
|
|
Nov 15
2020
|
Ronald Centis SVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
726
-5.27%
|
$8,712
$12.65 P/Share
|
|
Nov 15
2020
|
Thomas R Stanton Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,154
-2.67%
|
$73,848
$12.65 P/Share
|
|
Nov 15
2020
|
James Denson Wilson Jr Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,086
-3.82%
|
$13,032
$12.65 P/Share
|
|
Nov 15
2020
|
Michael Foliano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,070
-3.73%
|
$12,840
$12.65 P/Share
|
|
Nov 15
2020
|
Eduard Scheiterer SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
677
-2.98%
|
$8,124
$12.65 P/Share
|
|
Nov 15
2020
|
Marc Kimpe SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
691
-3.79%
|
$8,292
$12.65 P/Share
|
|
Nov 12
2020
|
Thomas R Stanton Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,134
-0.92%
|
$25,608
$12.33 P/Share
|
|
Nov 12
2020
|
James Denson Wilson Jr Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
475
-1.64%
|
$5,700
$12.33 P/Share
|
|
Nov 12
2020
|
Michael Foliano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
375
-1.29%
|
$4,500
$12.33 P/Share
|
|
Nov 12
2020
|
Eduard Scheiterer SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-1.35%
|
$3,744
$12.33 P/Share
|
|
Nov 12
2020
|
Marc Kimpe SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
259
-1.4%
|
$3,108
$12.39 P/Share
|
|
Nov 11
2020
|
Eduard Scheiterer SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,007
-1.72%
|
$12,084
$12.51 P/Share
|
|
Nov 11
2020
|
Thomas R Stanton Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,003
-0.85%
|
$24,036
$12.51 P/Share
|
|
Nov 11
2020
|
Michael Foliano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
327
-1.11%
|
$3,924
$12.51 P/Share
|
|
Nov 11
2020
|
James Denson Wilson Jr Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
431
-1.47%
|
$5,172
$12.51 P/Share
|
|
Nov 11
2020
|
Marc Kimpe SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
257
-1.37%
|
$3,084
$12.51 P/Share
|
|
Nov 09
2020
|
Thomas R Stanton Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,130
-1.32%
|
$34,430
$11.77 P/Share
|